Prosecution Insights
Last updated: April 19, 2026

Therapeutic Solutions International, Inc.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
0
Final Rejections
6
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18410531 PREDICTION OF STEM CELL THERAPY RESPONSIVENESS BY QUANTIFICATION OF PRE-EXISTING B REGULATORY CELLS THUESON, HANNA MARIE 1638 Non-Final OA Jan 11, 2024
18508623 TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MYELOID DERIVED SUPPRESSOR CELLS WRIGHT, ERIC BRANDON 1632 Non-Final OA Nov 14, 2023
18457605 GENE SILENCING THERAPY OF ACUTE RESPIRATORY DISORDER YU, DELPHINUS DOU YI 1636 Non-Final OA Aug 29, 2023
18449657 TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY MESENCHYMAL STEM CELL APOPTOTIC BODIES AND COMPOSITIONS THEREOF AMICK, THOMAS RUSSE 1638 Non-Final OA Aug 14, 2023
18361712 GENE MODIFIED IPSC DERIVED CELLULAR COMPOSITIONS FOR REGENERATION AND IMMUNE MODULATION PRONZATI, GINA 1633 Non-Final OA Jul 28, 2023
18316084 INHIBITION AND REVERSION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) BY ENDOTHELIAL CELL REGENERATION SCHWECHTER, BRANDON ROSS 1674 Non-Final OA May 11, 2023

Managing Therapeutic Solutions International, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month